1st Quarter - Report

CROSSROADS STRATEGIES, LLC for EISAI, INC.

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Regulatory and legislative health care issues, including: Alzheimer's drug development; Drug Pricing; Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA).

LobbyistCovered position, as disclosed
BRITTANY JOHNSON HERNANDEZ —
MATHEW LAPINSKI —
STEPHANIE LEGER New Deputy Projects Director, Sen. Mary Landrieu; Counsel, Sen. John Breaux
JASON BENJAMIN VAN PELT —

Contacted: Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

General issues related to Medicare and Medicaid, including: Part D Medicare Program; Drug Pricing; CMS NCD for Alzheimer's Drugs; H.R.5376, Inflation Reduction Act of 2022 (P.L.117-169) implementation; CMMI Proposed Accelerated Approval Payment Policy.

LobbyistCovered position, as disclosed
BRITTANY JOHNSON HERNANDEZ —
MATHEW LAPINSKI —
STEPHANIE LEGER New Deputy Projects Director, Sen. Mary Landrieu; Counsel, Sen. John Breaux
JASON BENJAMIN VAN PELT —

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE

Bills named: H.R. 5376 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.